Femasys (FEMY) Stock: Buy, Sell, or Hold?
FEMY - Femasys Inc. Common Stock
$2.05
-0.05 (-2.38%)
▼
5d:
-17.34%
30d:
-33.87%
90d:
-49.75%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When FEMY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: FEMY is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: FEMY is down 17.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: FEMY is currently trading at $2.05, which is considered oversold relative to its 30-day fair value range of $2.33 to $3.02.
Technical Outlook: Technically, FEMY is in a downtrend. Immediate support is located at $1.96, while resistance sits at $2.69.
Market Sentiment: FEMY scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.33 (+599.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FEMY is in a downtrend. Immediate support is located at $1.96, while resistance sits at $2.69.
Market Sentiment: FEMY scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $14.33 (+599.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.33 -
$3.02
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 599.2% below Wall St target ($14.33)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.33 -
$3.02
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.96
Resistance Level
$2.69
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.96
Wall Street Target
$14.33
(+599.2%)
Revenue Growth (YoY)
-18.9%
Share & Embed Analysis
Last updated: October 03, 2026 9:57 PM ET
Data refreshes hourly during market hours. Next update: 10:57 PM
Data refreshes hourly during market hours. Next update: 10:57 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FEMY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$84 | 53 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$476 | 35 SELL |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$66 | 67 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$250 | 61 BUY |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$206 | 65 BUY |
